Core Viewpoint - The company, Ying Sheng Science (00209), anticipates a loss of approximately HKD 38 million for the reporting period ending June 30, 2025, compared to a loss of about HKD 27 million in the same period last year [1] Summary by Relevant Categories Financial Performance - The expected loss for the reporting period is approximately HKD 38 million, which represents an increase from the HKD 27 million loss recorded in the previous year [1] Factors Influencing Performance - The widening loss is primarily attributed to two factors: 1. Increased tariffs imposed by the U.S. on Chinese goods, leading to a decrease in average product orders and gross profit compared to the same period last year, resulting in reduced sales and gross profit contributions [1] 2. Rising minimum wage and social insurance costs in mainland China [1]

Core Viewpoint - The company, Ying Sheng Science (00209), anticipates a loss of approximately HKD 38 million for the reporting period ending June 30, 2025, compared to a loss of about HKD 27 million in the same period last year [1] Financial Performance - The expected loss has widened primarily due to (i) the impact of increased tariffs imposed by the U.S. on China, leading to a decrease in average product orders and gross profit compared to the same period last year, resulting in reduced sales and gross profit contributions [1] - (ii) An increase in minimum wage and social insurance costs in mainland China has also contributed to the widening loss [1]

格隆汇8月15日丨瀛晟科学(00209.HK)公布，集团预计截至2025年6月30日止六个月录得约38百万港元亏 损，而去年同期则录得约27百万港元亏损。 报告期业绩亏损扩大主要是(i)由于美国对华增加关税影响下，客户平均产品订单及毛利均比去年同期下 降，销售及毛利贡献减少及(ii)内地最低工资及社会保险费用增加。 ...

格隆汇8月15日丨瀛晟科学(00209.HK)宣布，本公司的董事会会议将于2025年8月29日（星期五）举行， 藉以（其中包括）批准本公司及其附属公司截至2025年6月30日止六个月的中期业绩，及建议宣派中期 股息（如有）的事宜。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 WINSHINE SCIENCE COMPANY LIMITED 承董事會命 瀛晟科學有限公司 主席 蔣青輝 香港，二零二五年八月十五日 於本公告日期，董事會由四名執行董事蔣青輝先生（主席）、翁祖鈿先生（行政總裁）、李 忠海先生及汪曉峰先生；一名非執行董事林少鵬先生；及一名獨立非執行董事王鈺梅女 士組成。 * 僅供識別 * 209 董事會會議通告 瀛晟科學有限公司（「本公司」）董事會（「董事會」）欣然宣佈，本公司之董事會會議將於二 零二五年八月二十九日（星期五）舉行，藉以（其中包括）批准本公司及其附屬公司截至二 零二五年六月三十日止六個月之中期業績，及建議宣派中期股息（如有）之事宜。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 本公司董事會（「董事會」）謹此知會本公司股東（「股東」）及潛在投資者，根據對本集團截 至二零二五年六月三十日止六個月（「報告期」）未經審核綜合管理賬目的初步評估及董事 會目前可取得之資料，本公司預計報告期錄得約38百萬港元虧損，而去年同期則錄得約 27百萬港元虧損。報告期業績虧損擴大主要是(i)由於美國對華增加關稅影響下，客戶平 均產品訂單及毛利均比去年同期下降，銷售及毛利貢獻減少及(ii)內地最低工資及社會保 險費用增加。 截至本公告日期，本公司仍在落實本集團報告期之綜合財務資料。本公告所載之資料僅 根據本公司管理層參考現時可得資料（包括本集團報告期未經審核管理賬目）作出之初步 評估而得出，有關綜合管理賬目尚未經本公司核數師審核或經本公司審核委員會審閱， 有待落實及作出必要調整（如有）。本公司股東及潛在投資者應細閱關於本集團截至二零 二五年六月三十日止六個月的中期業績公告，該公告預計將於二零二五年八月 ...

瀛晟科学发布截至2024年12月31日止年度业绩，收入约5.16亿港元，同比减少1.41%;股东应占亏损 7302.6万港元，同比扩大154.89%;每股亏损56.4港仙。 香港联交所最新资料显示，8月14日，瀛晟科学(00209)股东将股票存入中策富汇证券，存仓市值977.99 万港元，占比8.43%。 ...

Group 1 - The core viewpoint of the article highlights the financial performance of Ying Sheng Science, indicating a decline in revenue and an increase in losses for the fiscal year ending December 31, 2024 [1] - Ying Sheng Science reported a revenue of approximately 516 million HKD, representing a year-on-year decrease of 1.41% [1] - The company experienced a shareholder loss of 73.026 million HKD, which is an increase of 154.89% compared to the previous year [1] - The loss per share was reported at 56.4 HKD cents [1] Group 2 - On August 14, shareholders of Ying Sheng Science deposited stocks into Zhongcai Fuhui Securities, with a market value of 9.7799 million HKD, accounting for 8.43% of the total [1]

Group 1 - A total of 193 stocks reached a 52-week high as of August 13, with notable performers including Ying Sheng Science (00209) at 288.46%, Lu Qing Entertainment (08052) at 36.47%, and Songjing Technology (01079) at 36.36% [1] - The closing price for Ying Sheng Science was 0.750, with a peak price of 1.010, indicating significant growth [1] - Lu Qing Entertainment closed at 0.115, reaching a high of 0.116, while Songjing Technology had a closing price of 0.490 and a peak of 0.750 [1] Group 2 - Other notable stocks that reached new highs include Zhonghui Biological (02627) with a high rate of 34.29%, Li Ji (00637) at 33.84%, and Huashang Energy (00206) at 30.77% [1] - The list of stocks achieving new highs includes various sectors, indicating a broad market interest [1] - The data reflects a positive trend in the market, with many companies experiencing substantial increases in their stock prices [1]

Group 1 - The company Ying Sheng Science (00209) announced that Guo Jianxiong has resigned as an independent non-executive director and will no longer serve as a member of the nomination committee for the audit committee, effective from August 8, 2025 [1] - The reason for the resignation is Guo Jianxiong's desire to allocate more time to personal and other business commitments [1]